Evaluation of the Clinical Parameters and Kinesiophobia in Femoroacetabular Impingement Syndrome
NCT ID: NCT06198829
Last Updated: 2025-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
22 participants
OBSERVATIONAL
2024-02-06
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Causes of Kinesiophobia in Lymphedema
NCT05105594
The Effect of Sacroiliac and Lumbar Mobilizations Applied in Addition to Conventional Physical Therapy
NCT07285876
Efficacy Of Activity-Based Intervention On Activity, Participation And Kinesiophobia In Patients With Tendon Injury
NCT05148585
Investigation of the Effectiveness of Dynamic Neuromuscular Stabilization Exercises After Lumbar Disc Herniation Surgery
NCT06005948
Evaluation of Spine Posture, Trunk Position Sense and Gait in Axial Spondyloarthritis Patients
NCT05038189
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Symptomatic patients with Femoroacetabular Impingement Syndrome (FAIS) typically present with pain, primarily in the groin but also potentially in the lower back, hip, and posterior thigh. In addition to pain, patients may complain of a mechanically perceptible 'click' sound, locking sensation, or instability in the hip. Symptoms particularly worsen with activities such as squatting, hip rotation, sitting, climbing stairs, and prolonged sitting. The resulting symptoms lead to a decrease in functional capacities related to physical activities.
The radiographic measurements of the FAIS-Cam deformity are typically done using the alpha angle. An angle of 58 degrees or higher is considered abnormal. However, abnormal morphology is not always indicative of a pathological lesion. A holistic approach, including patient symptoms and a physical examination, is necessary for a comprehensive assessment.
In patients with Femoroacetabular Impingement Syndrome (FAIS), hip biomechanics notably change during activities such as walking, squatting, and climbing stairs. Due to pain, individuals with FAIS may exhibit protective behaviors, such as keeping the hip in flexion or adopting a Trendelenburg gait to avoid loading forces on the extremity. This situation can lead to kinesiophobia, defined as an exaggerated fear of movement and avoidance behavior based on the belief that movement may lead to injury. In patients with FAIS, it is believed that high levels of kinesiophobia are associated with lower physical function.
The participants' sociodemographic information will be recorded using a Sociodemographic Information Form. For pain assessment, the Visual Analog Scale and Algometer will be employed. Joint range of motion will be measured using the Clinometer mobile application, hip asymmetry will be assessed through the Weight Bearing Asymmetry Test using a scale, movement fear will be gauged using the Tampa Kinesiophobia Scale, and hip dysfunction will be evaluated using the Harris Hip Score. Additionally, the "Sit-to-Stand Test" will be utilized for functional measurement. The alpha angle for patients will be evaluated through pelvic anteroposterior radiography.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clinical parameter assessment group
Various assessments will be conducted on patients with femoroacetabular cam impingement.
Physical examination tests and surveys
Patients'hip joint range of motion range of motion, pain levels, pressure-pain threshold levels, kinesiophobia levels, and hip dysfunction levels will be measured, and the alpha angle will be evaluated on hip radiographs.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical examination tests and surveys
Patients'hip joint range of motion range of motion, pain levels, pressure-pain threshold levels, kinesiophobia levels, and hip dysfunction levels will be measured, and the alpha angle will be evaluated on hip radiographs.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being diagnosed with 'cam' type femoroacetabular impingement syndrome
* Having no surgical history in the hip area and its vicinity within the last 1 year
* Having filled out the informed consent form
Exclusion Criteria
* Having another illness with symptoms that may overlap with FAI symptoms
* Refusing to participate in the study
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Medipol University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yagmur Kucuk
Research Assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gulay Aras Bayram, Assist.Prof.
Role: STUDY_DIRECTOR
Istanbul Medipol University School of Health Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Acibadem Atasehir Hospital
Istanbul, Atasehir, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ACU-FTR-YK-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.